329 related articles for article (PubMed ID: 17591892)
1. Impaired th1/tc1 cytokine production of tumor-infiltrating lymphocytes in a model of primary intraocular B-cell lymphoma.
Touitou V; Daussy C; Bodaghi B; Camelo S; de Kozak Y; Lehoang P; Naud MC; Varin A; Thillaye-Goldenberg B; Merle-Béral H; Fridman WH; Sautès-Fridman C; Fisson S
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3223-9. PubMed ID: 17591892
[TBL] [Abstract][Full Text] [Related]
2. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
Pellegrini P; Berghella AM; Contasta I; Adorno D
Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
[TBL] [Abstract][Full Text] [Related]
3. Combined CD4+ Th1 effect and lymphotactin transgene expression enhance CD8+ Tc1 tumor localization and therapy.
Huang H; Bi XG; Yuan JY; Xu SL; Guo XL; Xiang J
Gene Ther; 2005 Jun; 12(12):999-1010. PubMed ID: 15789061
[TBL] [Abstract][Full Text] [Related]
4. Impact of plastic adhesion in vitro on analysis of Th1 and Th2 cytokines and immune cell distribution from mice with multiple low-dose streptozotocin-induced diabetes.
Thorvaldson L; Johansson SE; Höglund P; Sandler S
J Immunol Methods; 2005 Dec; 307(1-2):73-81. PubMed ID: 16263129
[TBL] [Abstract][Full Text] [Related]
5. Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas.
Ben Abdelwahed R; Donnou S; Ouakrim H; Crozet L; Cosette J; Jacquet A; Tourais I; Fournès B; Gillard Bocquet M; Miloudi A; Touitou V; Daussy C; Naud MC; Fridman WH; Sautès-Fridman C; Urbain R; Fisson S
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3657-65. PubMed ID: 23611989
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy.
Jung U; Foley JE; Erdmann AA; Toda Y; Borenstein T; Mariotti J; Fowler DH
Biol Blood Marrow Transplant; 2006 Sep; 12(9):905-18. PubMed ID: 16920556
[TBL] [Abstract][Full Text] [Related]
7. The mouse chorionic gonadotropin beta-subunit-like (muCG beta l) molecule produced by tumor cells elicits the switch of T-cell immunity response from TH2 to TH1 in mice immunized with DNA vaccine based on rhesus monkey homologous CG beta (rmCG beta).
Shi SQ; Peng JP; Xu L; Yang Y; Chen Y
J Gene Med; 2005 Jan; 7(1):87-96. PubMed ID: 15517553
[TBL] [Abstract][Full Text] [Related]
8. Committed memory effector type 2 cytotoxic T (Tc2) cells are ineffective in protective anti-tumor immunity.
Do JS; Choi YH; Shin SH; Yi HK; Hwang PH; Nam SY
Immunol Lett; 2004 Aug; 95(1):77-84. PubMed ID: 15325801
[TBL] [Abstract][Full Text] [Related]
9. Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer.
Reome JB; Hylind JC; Dutton RW; Dobrzanski MJ
Clin Immunol; 2004 Apr; 111(1):69-81. PubMed ID: 15093554
[TBL] [Abstract][Full Text] [Related]
10. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
11. Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry.
Ito N; Nakamura H; Tanaka Y; Ohgi S
Cancer; 1999 Jun; 85(11):2359-67. PubMed ID: 10357406
[TBL] [Abstract][Full Text] [Related]
12. Induction of ocular inflammation by T-helper lymphocytes type 2.
Kim SJ; Zhang M; Vistica BP; Chan CC; Shen DF; Wawrousek EF; Gery I
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):758-65. PubMed ID: 11867595
[TBL] [Abstract][Full Text] [Related]
13. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions.
Sugita S; Usui Y; Horie S; Futagami Y; Aburatani H; Okazaki T; Honjo T; Takeuchi M; Mochizuki M
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2862-70. PubMed ID: 19182257
[TBL] [Abstract][Full Text] [Related]
14. Cytokine profiles and inflammatory cells during HSV-1-induced acute retinal necrosis.
Zheng M; Atherton SS
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1356-63. PubMed ID: 15790902
[TBL] [Abstract][Full Text] [Related]
15. Regulatory role of pro-Th1 and pro-Th2 cytokines in modulating the activity of Th1 and Th2 cells when B cell and macrophages are used as antigen presenting cells.
Singh V; Agrewala JN
BMC Immunol; 2006 Aug; 7():17. PubMed ID: 16889674
[TBL] [Abstract][Full Text] [Related]
16. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
[TBL] [Abstract][Full Text] [Related]
17. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
[TBL] [Abstract][Full Text] [Related]
19. Blockade of transforming growth factor beta upregulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa.
Di Sabatino A; Pickard KM; Rampton D; Kruidenier L; Rovedatti L; Leakey NA; Corazza GR; Monteleone G; MacDonald TT
Gut; 2008 May; 57(5):605-12. PubMed ID: 18178611
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of chimeric immunoreceptor gene-modified Tc1 and Th1 cells against autologous carcinoembryonic antigen-expressing colon cancer cells.
Sasaki T; Ikeda H; Sato M; Ohkuri T; Abe H; Kuroki M; Onodera M; Miyamoto M; Kondo S; Nishimura T
Cancer Sci; 2006 Sep; 97(9):920-7. PubMed ID: 16856879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
